---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-123289"
form_type: "8-K"
ticker: "NEUP"
cik: "0001191070"
company_name: "Neuphoria Therapeutics Inc."
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:42:35.609082+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Neuphoria Therapeutics regains Nasdaq compliance after holding 2025 annual meeting

## Summary
- Received Nasdaq deficiency notice on July 18, 2025 for failing to hold annual meeting within 12 months of FY end (Rule 5620(a)).
- Held 2025 annual shareholder meeting on December 12, 2025, satisfying the compliance requirement.
- Nasdaq confirmed on December 18, 2025 that the company has regained compliance; matter is closed.
- Previously disclosed delisting risk related to meeting requirement is now resolved.

## SEC filing metadata
- accession: 0001213900-25-123289
- form_type: 8-K
- ticker: NEUP
- cik: 0001191070
- company_name: Neuphoria Therapeutics Inc.
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1191070/000121390025123289/0001213900-25-123289-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1191070/000121390025123289/ea0270248-8k_neuphoria.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-123289
- JSON: https://secwatch.observer/filing/0001213900-25-123289.json
- Plain text: https://secwatch.observer/filing/0001213900-25-123289.txt

## Source-grounded claims
- claim_id: df3eb2f3e2b01c226b876714f3a8e4f719980a82
  claim: Neuphoria Therapeutics Inc. received a nasdaq compliance regained notice regarding shareholders (rules 5620(a)).
  evidence_excerpt: ompany was not in compliance with Nasdaq Listing Rule 5620(a) (the “ Listing Rule ”) as a result of the Company’s failure to hold a qualified annual meeting of stockholders within twelve months of the end of the Company’s fiscal year ended June
  evidence_url: https://www.sec.gov/Archives/edgar/data/1191070/000121390025123289/0001213900-25-123289-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.